Investment Stage – Series A
Gyroscope discover, develop and deliver innovative medicines to preserve people’s sight and fight the devastating impact of blindness around the world.
Spex Capital Ltd is an appointed representative of J8 Capital Management LLP which is authorised and regulated by the Financial Conduct Authority.
©2022 · Spex Capital
©2021 · Spex Capital